Ordinary Adjustment | Morgan Stanley U.S. Small Cap Biotechnology Index | Effective Date 3rd November 2025
Morgan Stanley U.S. Small Cap Biotechnology Index:
In the ordinary adjustment, the following composition will be implemented effective open 3rd November 2025:
| ACADIA PHARMACEUTICALS INC |
| ADMA BIOLOGICS INC |
| AGIOS PHARMACEUTICALS INC |
| AMICUS THERAPEUTICS INC |
| AMNEAL PHARMACEUTICALS INC |
| AMYLYX PHARMACEUTICALS INC |
| ANI PHARMACEUTICALS INC |
| APOGEE THERAPEUTICS ORD |
| ARCELLX INC |
| ARCUTIS BIOTHERAPEUTICS INC |
| ARDELYX INC |
| BEAM THERAPEUTICS INC |
| BIOCRYST PHARMACEUTICALS INC |
| CATALYST PHARMACEUTICALS INC |
| CELCUITY INC |
| CG ONCOLOGY INC |
| CIDARA THERAPEUTICS INC |
| COGENT BIOSCIENCES INC |
| CRINETICS PHARMACEUTICALS INC |
| DENALI THERAPEUTICS INC |
| DIANTHUS THERAPEUTICS INC |
| DISC MEDICINE INC |
| DYNE THERAPEUTICS INC |
| HARMONY BIOSCIENCES HOLDINGS INC |
| IDEAYA BIOSCIENCES INC |
| IMMUNOME INC |
| IMMUNOVANT INC |
| INDIVIOR PLC |
| INTELLIA THERAPEUTICS INC |
| JANUX THERAPEUTICS INC |
| KRYSTAL BIOTECH INC |
| KYMERA THERAPEUTICS INC |
| LIGAND PHARMACEUTICALS INC |
| LIQUIDIA TECHNOLOGIES INC |
| MANNKIND CORP |
| MINERALYS THERAPEUTICS ORD |
| MIRUM PHARMACEUTICALS INC |
| NEKTAR THERAPEUTICS |
| NEW BIOHAVEN |
| NOVAVAX INC |
| NUVATION BIO INC |
| Nuvalent Inc |
| OCULAR THERAPEUTIX INC |
| ORGANON & CO |
| PERRIGO CO PLC |
| PRESTIGE CONSUMER HEALTHCARE INC |
| PROTAGONIST THERAPEUTICS INC |
| Praxis Precision Medicines Inc |
| SAREPTA THERAPEUTICS INC |
| SCHOLAR ROCK HOLDING CORP |
| SOLENO THERAPEUTICS INC |
| SPYRE THERAPEUTICS INC |
| STOKE THERAPEUTICS INC |
| SUPERNUS PHARMACEUTICALS INC |
| SYNDAX PHARMACEUTICALS INC |
| TARSUS PHARMACEUTICALS INC |
| TG THERAPEUTICS INC |
| TRAVERE THERAPEUTICS INC |
| ULTRAGENYX PHARMACEUTICAL INC |
| VERA THERAPEUTICS INC |
| VIKING THERAPEUTICS INC |
| VIRIDIAN THERAPEUTICS INC |
| XERIS BIOPHARMA HOLDINGS INC |